New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Royalty Pharma plc
RPRX
Shape
US Flag

NASDAQ

14B

Biotechnology

Next Earning date - 08 May 2025

14B

Biotechnology

Next Earning date - 08 May 2025

32.75USD

Shape-0.26 ( -0.79%)
sun-fogPre-market 33.79$arrow-right-up0.00 (0.00%)
Market Closed (as of Mar 10, 20:00 EDT)
favorite-chart

Relative Strenght

92
favorite-chart

Volume Buzz

18%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

4%

Quote Panel

Shape
Updated March 11, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

RPRX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3B

Shape416%

2025-Revenue

$4.70

Shape921%

2025-EPS

$2B

Shape444%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

UBS

downgrade

Previous: Buy

2024-06-03

Now: Neutral

UBS

initialise

Previous: Not converted

2022-06-13

Now: Buy

Goldman Sachs

initialise

Previous: Not converted

2022-04-27

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+162%

1.6
vs 0.61

Q2.23

arrow
arrow

+8%

0.85
vs 0.79

Q3.23

arrow
arrow

+8%

0.79
vs 0.73

Q4.23

arrow
arrow

-26%

1.15
vs 1.56

Q1.24

arrow
arrow

-39%

0.98
vs 1.6

Q2.24

arrow
arrow

+13%

0.96
vs 0.85

Q3.24

arrow
arrow

+32%

1.04
vs 0.79

Q4.24

arrow
arrow

N/A

1.15
vs 1.15

Q1.25

arrow
arrow

+9%

1.07
vs 0.98

Q2.25

arrow
arrow

+4%

1
vs 0.96

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+22%

684M  vs 562M

Q2.23

arrow
arrow

+0%

538.2M  vs 536M

Q3.23

arrow
arrow

-6%

536.3M  vs 573.5M

Q4.23

arrow
arrow

+5%

596M  vs 565.7M

Q1.24

arrow
arrow

-17%

568M  vs 684M

Q2.24

arrow
arrow

0%

537.3M  vs 538.2M

Q3.24

arrow
arrow

+5%

564.7M  vs 536.3M

Q4.24

arrow
arrow

0%

594M  vs 596M

Q1.25

arrow
arrow

+28%

727.6M  vs 568M

Q2.25

arrow
arrow

+27%

682.5M  vs 537.3M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+6%

0.06
vs -0.11

Q2.23

arrow
arrow

+4%

0.04
vs 0.06

Q3.23

arrow
arrow

+1%

0.01
vs 0.04

Q4.23

arrow
arrow

+8%

0.08
vs 0.01

Q1.24

arrow
arrow

+0%

0
vs 0.08

Q2.24

arrow
arrow

+2%

0.02
vs 0

Q3.24

arrow
arrow

+8%

0.08
vs 0.02

Q4.24

arrow
arrow

+2%

0.02
vs 0.08

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

335

335
vs 339

-1%

Q2.23

arrow
arrow

332

332
vs 335

-1%

Q3.23

arrow
arrow

322

322
vs 332

-3%

Q4.23

arrow
arrow

368

368
vs 322

14%

Q1.24

arrow
arrow

383

383
vs 368

4%

Q2.24

arrow
arrow

382

382
vs 383

0%

Q3.24

arrow
arrow

398

398
vs 382

4%

Q4.24

arrow
arrow

412

412
vs 398

4%

Earnings Growth

Latest News